FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/095804 [Registered on: 09/10/2025] Trial Registered Prospectively
Last Modified On: 07/10/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Studying the nutritional value of Shramahara Mahakashaya granules and checking how well they help reduce weakness and tiredness in working women 
Scientific Title of Study   Nutritional analysis of Shramahara Mahakashaya granules and its efficacy in the management of General Debility Syndrome among working women - A Pilot Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Padmaja Prashant Wanjari 
Designation  PG Scholar 
Affiliation  Research Institution and Hospital 
Address  Room no 30 Department of Samhita Siddhant Mahatma Gandhi Ayurved College hospital and Research Centre Salod H Wardha 442001 Maharashtra
Department of Samhita Siddhant Panini lab Wardha MAHARASHTRA 442001 India
Wardha
MAHARASHTRA
442001
India 
Phone  9610332268  
Fax    
Email  padmajawanjari@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Dnyanesh Joshi 
Designation  Professor 
Affiliation  Research Institution and Hospital 
Address  Room no 21 Department of Samhita Siddhant Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Wardha 442001 Maharashtra
Department of Samhita Siddhant Panini lab Wardha MAHARASHTRA 442001 India
Wardha
MAHARASHTRA
442001
India 
Phone  8087374390  
Fax    
Email  dnyanesh.joshi@dmiher.edu.in  
 
Details of Contact Person
Public Query
 
Name  Padmaja Prashant Wanjari 
Designation  PG Scholar 
Affiliation  Research Institution and Hospital 
Address  Room no 30 Department of Samhita Siddhant Mahatma Gandhi Ayurved College and Research Centre Salod Wardha 442001 Maharashtra
Department of Samhita Siddhant Panini lab Wardha MAHARASHTRA 442001 India
Wardha
MAHARASHTRA
442001
India 
Phone  9610332268  
Fax    
Email  padmajawanjari@gmail.com  
 
Source of Monetary or Material Support  
Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Wardha Maharashtra India 442001 
 
Primary Sponsor  
Name  Padmaja Prashant Wanjari 
Address  Department of Samhita Siddhant Mahatma Gandhi Ayurved College and Research Centre Salod Wardha Maharshtra India 442001  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Padmaja Wanjari  Mahatma Gandhi Ayurved College Hospital and Research Centre Wardha Maharashtra  Department of Kayachikitsa Wardha MAHARASHTRA 442001
Wardha
MAHARASHTRA 
9610332268

padmajawanjari@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Mahatma Gandhi Ayurveda college Research Centre Wardha State Maharashtra  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  General Debility Syndrome  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Shramahara Mahakashaya, Reference: Charak Samhita Sutra sthan 4/16, Route: Oral, Dosage Form: Khanda /Granules, Dose: 15(g), Frequency: od, Bhaishajya Kal: Abhakta, Duration: 14 Days, anupAna/sahapAna: Yes(details: -water), Additional Information: -
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  Female participants aged 25 to 45 years working in any occupation
Mild to Moderate fatigue with FAS score less than 36
Participants willing to participate and give written informed consent 
 
ExclusionCriteria 
Details  Women with diagnosed chronic illnesses such as diabetes mellitus, hypertension, thyroid disorders, cardiovascular diseases, chronic fatigue syndrome or autoimmune disorders
Participants currently taking nutritional supplements energy boosters or herbal formulations that may interfere with fatigue assessment
Women with psychiatric conditions such as depression, anxiety disorders or sleep disorders currently under treatment
Women who are pregnant or lactating
Women with a history of substance abuse
Participants who are unable to comply with the study protocol or follow-up visits 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Determination of Nutritional Composition of Shramahara Mahakashya Granules  2 months 
 
Secondary Outcome  
Outcome  TimePoints 
Effectiveness of Shramahara Mahakshaya Granules in General Debility Syndrome in Working Women  2 months 
 
Target Sample Size   Total Sample Size="15"
Sample Size from India="15" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="10"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The volunteers will be informed about the study protocol. Willing participants will be selected. Clinical research format will be prepared and validated. Prior to the study, approval will be taken from IEC, MGACHRC, Salod (H), Wardha and CTRI registration will be done. After selection, each participant will be assessed individually and selected according to the selection criteria. The study will be carried over a period of 14 days, which will include the treatment period as well as follow ups. Data will be collected and analized accordingly. 
Close